CDK4/6 inhibitor (adjuvant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDK4/6 inhibitor (adjuvant), covering 2025-12-09 to 2025-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening